10 Versus 20 Minutes Treatment of Human Pericardium With Glutaraldehyde in OZAKI Procedure — 10vs20-OZAKI

Aortic Valve Surgery Clinical Trial

Official title:
10 Versus 20 Minutes Treatment of Human Pericardium With Glutaraldehyde in OZAKI Procedure

Status Completed

Clinical Trial Summary

To compare mechanic and thermic stability of pericardium fixated either with 0.6% glutaraldehyde for 10 minutes or with 0.6% glutaraldehyde for 20 minutes

Clinical Trial Description

Autologous pericardium for aortic valve reconstruction is treated with 0.6% glutaraldehyde for 10 minutes to improve stability (OKAZI technique).

This study investigates whether treatment with 0.6% glutaraldehyde for 20 minutes improves mechanic and thermic stability of autologous pericardial tissue. Autologous pericardium remaining after aortic valve reconstruction surgery is used.

To investigate 10 versus 20 minutes treatment of removed original aortic valve tissue with glutaraldehyde as a reference. ;

Study Design

Related Conditions & MeSH terms

Aortic Valve Surgery

Clinical Trial Details

NCT number	NCT03667235
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase
Start date	August 4, 2017
Completion date	October 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03079830` - Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery	N/A
Completed	`NCT02278666` - Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry
Recruiting	`NCT02627391` - Early Surgery for Patients With Asymptomatic Aortic Stenosis	N/A
Completed	`NCT03815188` - Use of the SonoSite Probe for Measuring Jugular Venous Pressure